Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Will Not Broadly Release Report Criticizing EU Oversight

This article was originally published in The Gray Sheet

Executive Summary

The agency decided not to widely disseminate a report examining 12 high-risk devices that were approved in Europe, but were later found to be dangerous or ineffective.


Related Content

FDA: Factoring In Reimbursement, U.S. Bests Europe In Access To Innovative Devices
International News In Brief
Device Innovation: Report Paints Dire Picture; Prez, FDA Take "Positive" Steps
Shuren: "We Don't Use Our People As Guinea Pigs In The U.S."
Firms Find FDA Less Efficient, Less Competent Than European Counterparts





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts